PRTA FY 2016 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-34.3% YoY

Gross Profit

-$118M-11230.2% margin

Operating Income

-$160M-15121.8% margin

Net Income

-$160M-15176.1% margin

EPS (Diluted)

$-4.66

Cash Flow

Operating Cash Flow

-$117M

Free Cash Flow

-$134M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$460M

Total Liabilities

$95M

Stockholders' Equity

$365M

Cash & Equivalents

$387M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$2M	-34.3%
Gross Profit	-$118M	-$57M	-108.5%
Operating Income	-$160M	-$80M	-99.6%
Net Income	-$160M	-$81M	-98.6%